Kewaunee Scientific stock carries an 11.93 price-to-earnings ratio

Published on 10/17/2026 at 22:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue was USD 66.32 million in fiscal first quarter 2027. Kewaunee Scientific stock was USD 32.92 on October 16, 2026, up 2.28 percent on Nasdaq.

Valuation and company dates

Kewaunee Scientific carried a price-to-earnings ratio of 11.93 as of October 16, 2026.
Fiscal first-quarter revenue was USD 66.32 million for the period ended July 31, 2026.
Kewaunee Scientific stock stood at USD 32.92 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, up 2.28 percent versus the prior close.
The next estimated earnings date is December 16, 2026.

KEQU, US4928541048, Illustration mit AI erstellt.

Kewaunee Scientific stock carries a trailing price-to-earnings ratio of 11.93 as of October 16, 2026, giving investors a concrete valuation measure for the laboratory-furniture maker. Kewaunee Scientific was last at USD 32.92 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, up 2.28 percent versus the prior close.

Fiscal revenue sets the second fact

Investing.com reported fiscal first-quarter revenue of USD 66.32 million for the period ended July 31, 2026. That was down from USD 71.40 million in the previous quarter, a decline of 7.11 percent on a sequential basis. The figure puts the valuation discussion against a business result rather than against the share price alone.

Kewaunee's investor-relations page describes a portfolio spanning laboratory casework, fume hoods, epoxy-resin worktops and adaptable systems for life-science, education, healthcare, industrial and government customers. The company says it combines manufacturing with installation and dealer distribution, which makes order timing and project execution important to the revenue path.

Stock sits near its yearly low

The Nasdaq price was USD 32.92 on October 16, 2026, while the 52-week range ran from USD 32.00 to USD 46.57. The stock therefore stood 2.88 percent above its 52-week low and 29.32 percent below its 52-week high. Trading volume reached 1,287 shares against an average of 4,273 shares, so the latest move came with volume at 30.12 percent of its average.

Valuation and December date

Kewaunee's market capitalization was USD 95.3 million on October 16, 2026, alongside the 11.93 price-to-earnings ratio. The company carried no dividend yield in the quoted figures. Stock Market Watch lists December 16, 2026 as an estimated next earnings date after the close.

Comparison with peers

Kewaunee Scientific: plus 2.28 percent, P/E 11.93, market capitalization USD 95.3 million
HNI Corporation (NYSE, USD): minus 0.40 percent, P/E 520.67, market capitalization USD 3.4 billion
Standard BioTools (Nasdaq, USD): minus 4.47 percent, P/E minus 2.73, market capitalization USD 246.9 million

What the next session starts from

Kewaunee's 11.93 price-to-earnings ratio is lower than HNI Corporation's 520.67 ratio but sits alongside a much smaller USD 95.3 million market value. The 52-week position leaves only USD 0.92 between the latest Nasdaq price and the yearly low, while the next estimated reporting date is December 16, 2026.